Xylem (XYL)
(Delayed Data from NYSE)
$126.71 USD
-1.32 (-1.03%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $126.78 +0.07 (0.06%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
XYL 126.71 -1.32(-1.03%)
Will XYL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for XYL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for XYL
Why Is Xylem (XYL) Up 1.7% Since Last Earnings Report?
Xylem (XYL) Stock Boasts Strong Prospects Despite Headwinds
XYL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xylem (XYL) Q2 Earnings & Revenues Beat, '24 View Raised
Compared to Estimates, Xylem (XYL) Q2 Earnings: A Look at Key Metrics
Xylem (XYL) Beats Q2 Earnings and Revenue Estimates
Other News for XYL
Xylem: Good Performance Likely To Be Fully Priced In
Integrated Solution from ElectraMet and Xylem to Simplify Metals Recovery for Battery Recycling and Semiconductor Manufacturers
XYL Makes Notable Cross Below Critical Moving Average
Xylem (XYL) Stock Drops Following Analyst Downgrade
Beyond The Numbers: 7 Analysts Discuss Xylem Stock